NCT02117284View on ClinicalTrials.gov

Rubidium Elution System Performance Testing

CompletedOBSERVATIONAL
Enrollment

15,800

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Coronary Artery Disease
Trial Locations (4)

Unknown

Hamilton Healath Sciences Centre, Hamilton

London Health Sciences Centre, London

University Health Network, Toronto

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
collaborator

Jubilant DraxImage Inc.

INDUSTRY

lead

Ottawa Heart Institute Research Corporation

OTHER

NCT02117284 - Rubidium Elution System Performance Testing | Biotech Hunter | Biotech Hunter